BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 17590173)

  • 21. [Abnormal T cell maturation in myasthenia gravis associated thymomas].
    Nenninger R; Schultz A; Müller-Hermelink HK; Marx A
    Verh Dtsch Ges Pathol; 1996; 80():256-60. PubMed ID: 9065022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thymoma Associated Myasthenia Gravis (TAMG): Differential Expression of Functional Pathways in Relation to MG Status in Different Thymoma Histotypes.
    Yamada Y; Weis CA; Thelen J; Sticht C; Schalke B; Ströbel P; Marx A
    Front Immunol; 2020; 11():664. PubMed ID: 32373124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paraneoplastic autoimmunity in thymus tumors.
    Marx A; Schultz A; Wilisch A; Helmreich M; Nenninger R; Müller-Hermelink HK
    Dev Immunol; 1998; 6(1-2):129-40. PubMed ID: 9716914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Neurofilament expression in thymic epithelial tumors and anti-axonal autoantibodies in myasthenia gravis: a model for autoimmunity by abnormal T cell selection].
    Marx A; Kirchner T; Greiner A; Schalke B; Müller-Hermelink HK
    Verh Dtsch Ges Pathol; 1992; 76():256-61. PubMed ID: 1283271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal thymocyte development and generation of autoreactive T cells in mixed and cortical thymomas.
    Nenninger R; Schultz A; Hoffacker V; Helmreich M; Wilisch A; Vandekerckhove B; Hünig T; Schalke B; Schneider C; Tzartos S; Kalbacher H; Müller-Hermelink HK; Marx A
    Lab Invest; 1998 Jun; 78(6):743-53. PubMed ID: 9645765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunological function of thymoma and pathogenesis of paraneoplastic myasthenia gravis.
    Okumura M; Fujii Y; Shiono H; Inoue M; Minami M; Utsumi T; Kadota Y; Sawa Y
    Gen Thorac Cardiovasc Surg; 2008 Apr; 56(4):143-50. PubMed ID: 18401674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased expression of circulating Aire and increased Tfh/Tfr cells in myasthenia gravis patients.
    Zhao S; Ding J; Wang S; Li C; Guo P; Zhang M; Li Z
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 29773681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphocyte subpopulation in neoplastic and non-neoplastic thymus and in blood of patients with Myasthenia gravis.
    Shirai T; Miyata M; Nakase A; Itoh T
    Clin Exp Immunol; 1976 Oct; 26(1):118-23. PubMed ID: 1087211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinicopathological significance of thymic epithelial markers expression in thymoma and thymic carcinoma.
    Li H; Ren B; Yu S; Gao H; Sun PL
    BMC Cancer; 2023 Feb; 23(1):161. PubMed ID: 36797681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between structure and T-lymphocyte maturation in human thymomas. Enzyme histochemical and immunohistological studies.
    Palestro G; Valente G; Novero D; Stramignoni D; Geuna M; Rosai J
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1987; 52(5):389-402. PubMed ID: 2883762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thymoma related myasthenia gravis in humans and potential animal models.
    Marx A; Porubsky S; Belharazem D; Saruhan-Direskeneli G; Schalke B; Ströbel P; Weis CA
    Exp Neurol; 2015 Aug; 270():55-65. PubMed ID: 25700911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myasthenia gravis: immunohistological heterogeneity in microenvironmental organization of hyperplastic and neoplastic thymuses suggesting different mechanisms of tolerance breakdown.
    Chilosi M; Iannucci A; Fiore-Donati L; Tridente G; Pampanin M; Pizzolo G; Ritter M; Bofill M; Janossy G
    J Neuroimmunol; 1986 May; 11(3):191-204. PubMed ID: 3514666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of positive selection of thymoma-associated T cells in the pathogenesis of myasthenia gravis.
    Inada K; Okumura M; Shiono H; Inoue M; Kadota Y; Ohta M; Matsuda H
    J Surg Res; 2005 Jun; 126(1):34-40. PubMed ID: 15916972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Demonstration of phenotypic abnormalities of thymic epithelium in thymoma including two cases with abundant Langerhans cells.
    Kraus VB; Harden EA; Wittels B; Moore JO; Haynes BF
    Am J Pathol; 1988 Sep; 132(3):552-62. PubMed ID: 3261946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type B thymomas in patients with myasthenia gravis display a distinctive pattern of αβ TCR and IL-7 receptor α expression on CD4
    Wang T; Wang B; Fan X; Cai Y; Li L; Fu S
    Autoimmunity; 2024 Apr; 57(1):2347379. PubMed ID: 38723105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulation of Bcl-2 protein in the myasthenic thymus.
    Onodera J; Nakamura S; Nagano I; tobita M; Yoshioka M; Takeda A; Oouchi M; Itoyama Y
    Ann Neurol; 1996 Apr; 39(4):521-8. PubMed ID: 8619530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An immunohistologic study of the epithelial components of 81 cases of thymoma.
    Fukai I; Masaoka A; Hashimoto T; Yamakawa Y; Mizuno T; Tanamura O; Hirokawa K; Ueda R
    Cancer; 1992 May; 69(10):2463-8. PubMed ID: 1373667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thymic epithelial antigen, acquired during ontogeny and defined by the anti-p19 monoclonal antibody, is lost in thymomas.
    Savino W; Berrih S; Dardenne M
    Lab Invest; 1984 Sep; 51(3):292-6. PubMed ID: 6433106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathological aspects of malignant and benign thymic disorders.
    Müller-Hermelink HK; Marx A
    Ann Med; 1999 Oct; 31 Suppl 2():5-14. PubMed ID: 10574149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macrophages and interdigitating reticulum cells in normal thymus and in thymoma: an immunohistochemical study.
    Ruco LP; Rosati S; Monardo F; Pescarmona E; Rendina EA; Baroni CD
    Histopathology; 1989 Jan; 14(1):37-45. PubMed ID: 2925178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.